HIMSS19: Zynx Health Debuts Lumynz Solution to Assess the Utilization of Evidence-Based Interventions and Measure the Financial Impact to Healthcare Organizations

LOS ANGELES, Feb. 5, 2019 /PRNewswire/ -- Zynx Health™, a market leader in providing evidence- and experience-based clinical decision support since 1996, today announced the launch of Lumynz, a breakthrough surveillance and analytics SaaS platform that measures the utilization of evidence-based interventions and the impact on financial outcomes. Healthcare leaders attending next week’s HIMSS19 Global Conference and Exhibition in Orlando will have the opportunity to preview Lumynz and meet with Zynx Health representatives at Booth 1921.

Lumynz provides an interactive, retrospective analysis of provider orders utilization against evidence-based interventions that are proven to enhance outcomes. This analysis highlights how the interventions are being utilized by clinician staff, identifying opportunities to reduce unwarranted care variance. Lumynz enables leaders to engage with clinicians via targeted messages that guide patient care and improve the clinical decision process. Additionally, Lumynz evaluates if the care provided is accurately reflected in the Charge Description Master and on patient claims and identifies charge capture opportunities that have financial impact.

“To download the Lumynz logo, click here.”

“With Lumynz, hospitals have an interactive solution that helps them realize the full value of standardized clinical actions based on evidence,” said Kevin J. Daly, president of Zynx Health. “Over the last decade, organizations have invested millions to implement CPOE solutions that leverage evidence-based protocols, yet few hospitals have reliable solutions to verify clinicians are actually utilizing these interventions. Lumynz provides hospitals a way to measure adherence with evidence-based standards of care, allowing leaders to take appropriate action to ensure the delivery of the right patient care and more accurate charging. Furthermore, Lumynz enables hospital leaders to monitor whether initiatives to improve care are actually impacting clinician behavior.”

Dr. Kelly Philiba, the physician informatics specialist at Zynx Health’s innovation partner Health Quest, added that “Lumynz enabled us see the complete picture of our evidence-based practices from both clinical and financial perspectives. In March, we implemented a VTE prophylaxis alert but briefly turned it off in May to troubleshoot. Lumynz revealed the initial impact of a 20% increase in compliance with this vital intervention, reflected the oscillation with alert deactivation and reactivation, and provided concrete validation that (at minimum) 92% of heart failure patients are receiving evidence-based care. It was a retrospective enlightenment for us. Lumynz helps us to visualize these processes, and perhaps more importantly, the data gives us a means to delve into ‘why’ certain interventions are being employed. Lumynz continues to highlight areas of opportunity which empower our drive toward innovation and excellence.”

For more information about Lumynz or to schedule a meeting at HIMSS19, please visit: the Zynx Health HIMSS page.

About Zynx Health
Zynx Health, part of the Hearst Health network, provides healthcare professionals with vital information and processes that guide care decisions and reduce complexity across the entire patient journey in a way that leads to healthier lives for all. Zynx is a pioneer and market leader in evidence- and experience-based clinical solutions that help health systems improve patient outcomes, financial outcomes, clinical engagement, and technology performance. With Zynx Health, healthcare organizations exceed industry demands for delivering high-quality care at lower costs under value-based reimbursement models. To learn more, visit zynxhealth.com or call 855.367.ZYNX.

About Hearst Health
The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MedHOK and Hearst Health Ventures (www.hearsthealth.com). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 77 million home health visits and 3.2 billion dispensed prescriptions.

View original content to download multimedia:http://www.prnewswire.com/news-releases/himss19-zynx-health-debuts-lumynz-solution-to-assess-the-utilization-of-evidence-based-interventions-and-measure-the-financial-impact-to-healthcare-organizations-300789558.html

SOURCE Zynx Health